Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Three Companies Score Top Marks in Global Site Survey

June 6, 2011 12:03 pm | News | Comments

A CenterWatch survey shows drug sponsors have continued to improve relationships with investigative sites by focusing on strategies to improve site quality and performance.


Clavis Pharma Elects Robert J. Spiegel to its Board of Directors

June 6, 2011 12:00 pm | News | Comments

Clavis Pharma announces that Robert J. Spiegel, MD, has been elected to its board of directors.


Antisense Granted Patents on Portable System

June 6, 2011 11:56 am | News | Comments

Antisense Pharma GmbH announced the granting of patents for an application system, which for the first time allows long-term and outpatient administration of therapeutic substances into brain tissue using the Convection Enhanced Delivery (CED).


FDA Accepts Filing of New Drug Application for ciclesonide nasal aerosol

June 6, 2011 8:36 am | News | Comments

Nycomed's licensing partner Sunovion Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation.


Software for Increased Performance and Control

June 6, 2011 8:05 am | Product Releases | Comments

Freeslate Inc.’s Automation Studio 8.3 software, a component of its Lab Execution and Analysis (LEA) software suite, improves R&D productivity by automating and controlling multiple laboratory instruments with a single software interface.


Software for Scientists

June 6, 2011 7:58 am | Product Releases | Comments

Micronic’s Track-IT is an LIMS/LIS solution made for scientists, which helps re-organize and track tubes and samples.


IDBS and ChemAxon Extend Strategic Relationship

June 6, 2011 7:46 am | News | Comments

IDBS, a global provider of data management, analytics, and modeling solutions, and ChemAxon, a provider of cheminformatics software for the life sciences industry, announced the extension of their relationship.


Judge Orders Drug Company to Pay S.C. $327 Million

June 6, 2011 7:32 am | by Meg Kinnard, Associated Press | News | Comments

A Johnson & Johnson subsidiary must pay South Carolina $327 million for deceptive marketing of an antipsychotic drug, a Spartanburg County judge ruled June 3.


E.U. Approves Lucentis for Blocked Retinal Veins

June 6, 2011 6:50 am | News | Comments

Novartis says it has received European Union approval for its eye drug Lucentis to be used as a treatment for vision loss caused by blocked retinal veins.


Catumaxomab Triggers Vaccination Effect

June 6, 2011 6:44 am | News | Comments

Trion Pharma announced results from two studies demonstrating catumaxomab’s capacity to activate the immune system in a way that otherwise can only be achieved through vaccination.


Quadrupole Mass Spectrometry

June 6, 2011 5:54 am | Product Releases | Comments

Shimadzu Scientific Instruments’ ultra-fast mass spectrometry (UFMS) delivers speed without sacrificing sensitivity, resolution or mass range.


Mass Spectrometer

June 6, 2011 5:34 am | Product Releases | Comments

Thermo Fisher Scientific Inc.’s hybrid mass spectrometer, the Orbitrap Elite, offers a resolving power of 240,000 and a range of fragmentation techniques, helping customers explore challenges in proteomics, metabolomics, lipidomics and metabolism applications.


Sample Preparation

June 6, 2011 5:29 am | Product Releases | Comments

IonSense, Inc.’s ID CUBE Source with OpenSpot sample card can speed the analysis of new materials being created by synthetic and medicinal chemists in universities and pharmaceutical companies.


Benchtop Mass Spectrometer

June 6, 2011 4:53 am | Product Releases | Comments

Thermo Fisher Scientific Inc.’s Q Exactive benchtop quadrupole-Orbitrap brings together quadrupole precursor selection and high-resolution accurate mass Orbitrap mass analysis to deliver quantitative workflows.


FDA’s Five-Year Blueprint

June 3, 2011 12:23 pm | by Rita C. Peters, Editorial Director | Articles | Comments

Strategic plans are a lot like New Year’s resolutions. The creators have the best intentions, but implementing the plan may be another story.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.